Related references
Note: Only part of the references are listed.Evidence for an Unanticipated Relationship between Undifferentiated Pleomorphic Sarcoma and Embryonal Rhabdomyosarcoma
Brian P. Rubin et al.
CANCER CELL (2011)
Protein Kinase Cι Expression and Oncogenic Signaling Mechanisms in Cancer
Nicole R. Murray et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Protein Kinase Cι Is Required for Pancreatic Cancer Cell Transformed Growth and Tumorigenesis
Michele L. Scotti et al.
CANCER RESEARCH (2010)
Protection from Rapamycin-Induced Apoptosis by Insulin-Like Growth Factor-I Is Partially Dependent on Protein Kinase C Signaling
Kuntebommanahalli N. Thimmaiah et al.
CANCER RESEARCH (2010)
Targets for cancer therapy in childhood sarcomas
Marco Wachtel et al.
CANCER TREATMENT REVIEWS (2010)
Tiam1-Rac Signaling Counteracts Eg5 during Bipolar Spindle Assembly to Facilitate Chromosome Congression
Simon A. Woodcock et al.
CURRENT BIOLOGY (2010)
Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma
Koichi Nishijo et al.
CANCER RESEARCH (2009)
Atypical Protein Kinase Cι Is Required for Bronchioalveolar Stem Cell Expansion and Lung Tumorigenesis
Roderick P. Regala et al.
CANCER RESEARCH (2009)
Exploitation of protein kinase C: A useful target for cancer therapy
Ashhar S. Ali et al.
CANCER TREATMENT REVIEWS (2009)
Role of protein kinase C-iota in transformed non-malignant RWPE-1 cells and androgen-independent prostate carcinoma DU-145 cells
H. Y. Win et al.
CELL PROLIFERATION (2009)
Rhabdomyosarcoma in children
Andrea Hayes-Jordan et al.
CURRENT OPINION IN PEDIATRICS (2009)
aPKCλ/ι promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6
Hitoshi Ishiguro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Atypical protein kinase C phosphorylates IKKαβ in transformed non-malignant and malignant prostate cell survival
Hla Y. Win et al.
CANCER LETTERS (2008)
Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities
Ralf Amstutz et al.
CANCER RESEARCH (2008)
Atypical protein kinase CL expression and aurothiomalate sensitivity in human lung cancer cells
Roderick P. Regala et al.
CANCER RESEARCH (2008)
P21-activated kinase is required for mitotic progression and regulates Plk1
B. Maroto et al.
ONCOGENE (2008)
Targeting the oncogenic protein kinase Cl signalling pathway for the treatment of cancer
A. P. Fields et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Phosphorylation profiles of protein kinases in alveolar and embryonal rhabdomyosarcoma
Ling Cen et al.
MODERN PATHOLOGY (2007)
Targeting the protein kinase C family: are we there yet?
Helen J. Mackay et al.
NATURE REVIEWS CANCER (2007)
Protein kinase Cι:: Human oncogene, prognostic marker and therapeutic target
Alan P. Fields et al.
PHARMACOLOGICAL RESEARCH (2007)
Protein kinase C and other diacylglycerol effectors in cancer
Erin M. Griner et al.
NATURE REVIEWS CANCER (2007)
Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Cι
Eda Erdogan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Integrative genomic analysis of protein kinase C (PKC) family identifies PKCι as a biomarker and potential oncogene in ovarian carcinoma
Lin Zhang et al.
CANCER RESEARCH (2006)
A novel small-molecule inhibitor of protein kinase Cι blocks transformed growth of non-small-cell lung cancer cells
M Stallings-Mann et al.
CANCER RESEARCH (2006)
Atypical protein kinase Cι, is an oncogene in human non-small cell lung cancer
RP Regala et al.
CANCER RESEARCH (2005)
Atypical protein kinase Cι plays a critical role in human lung cancer cell growth and tumorigenicity
RP Regala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Protein kinase Cι is required for Ras transformation and colon carcinogenesis in vivo
NR Murray et al.
JOURNAL OF CELL BIOLOGY (2004)
Regulation of microtubule destabilizing activity of Op18/stathmin downstream of Rac1
T Wittmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of ADAM12 cell-surface expression by protein kinase C ε
C Sundberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function:: implications for alveolar rhabdomyosarcoma cell of origin
C Keller et al.
GENES & DEVELOPMENT (2004)
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice:: cooperativity of Ink4a/ARF and Trp53 loss of function
C Keller et al.
GENES & DEVELOPMENT (2004)
A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells -: art. no. 10
K Svensson et al.
BMC CANCER (2003)
Cell polarity: Par6, aPKC and cytoskeletal crosstalk
S Etienne-Manneville et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma - A report from the intergroup rhabdomyosarcoma study IV
JC Breneman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma:: A report from the children's oncology group
PHB Sorensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
